What To Know
- With its headquarters in the UAE M42 emerged as a global health leader that develops sophisticated AI solutions to transform medical services together with both clinical choices and preventive healthcare initiatives.
- The “Med42 LLM Model” serves as central to their innovations since it started as the first clinical large language model of October 2023 followed by an update in 2024.
- As the organization uses AI responsibility M42 uses this technology through safe applications to accelerate drug development and clinical trials and personalized treatments thus establishing worldwide standards for digital healthcare together with critical human presence.
The worldwide industry revolution through artificial intelligence (AI) has positioned healthcare as its leading sector for transformation. With its headquarters in the UAE M42 emerged as a global health leader that develops sophisticated AI solutions to transform medical services together with both clinical choices and preventive healthcare initiatives.
Before Arab Health 2025 Dr. Maaz Shaikh who serves as M42’s Vice President of Product Management explained the company’s recent breakthroughs. The “Med42 LLM Model” serves as central to their innovations since it started as the first clinical large language model of October 2023 followed by an update in 2024. The exceptional 94.5% rate in USMLE evaluations equips clinicians to condense complicated information into customized educational resources which fully supports evidence-based treatment decisions.
AI tools integrated into M42 remedy administrative strains by providing artificial intelligence-mediated documentation capabilities alongside note-taking functionalities that improve clinician time allocation toward patient directly care. Through the AIRIS-TB system M42 shows that AI technology can automate tuberculosis screening checks on 2,000 daily chest X-rays with 80% efficiency. Endoscopic imaging tools facilitate better anomaly detection and the Omics Centre of Excellence leads genomic research development through programs such as the UAE Genome Programme.
Ethics along with patient data privacy stand as paramount considerations at M42. Dr. Every AI application receives proper risk assessments to follow the utmost ethical guidelines during its implementation phase according to Shaikh. The compassionate care essence of M42’s mission needs human expertise to function in harmony with automated systems according to Dr. Shaikh.
The mission of M42 is to create healthier longer lives by supporting precision medical care and preventing illnesses. As the organization uses AI responsibility M42 uses this technology through safe applications to accelerate drug development and clinical trials and personalized treatments thus establishing worldwide standards for digital healthcare together with critical human presence.
